For research use only
| Cat No. | ABC-TC3038 |
| Product Type | Mouse Primary Cells |
| Cell Type | Macrophage |
| Species | B6129SF2/J Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Utilize B6129SF2/J Mouse Bone Marrow Macrophages to study immune responses and macrophage-mediated inflammation in murine bone marrow disease models.
B6129SF2/J Mouse Bone Marrow Macrophages are primary cells isolated from the femurs and tibias of pathogen-free adult B6129SF2/J mice, a hybrid strain derived from C57BL/6J and 129S1/SvImJ parental lines, and are suitable for B6129SF2/F macrophage culture applications. These cells exhibit typical macrophage morphology and express high levels of surface markers including F4/80, CD11b, and CD68. As key players in innate immunity, they participate in phagocytosis, antigen presentation, and cytokine secretion. These macrophages are cryopreserved at P0 and are non-proliferative without specific growth factors; repeated freeze-thaw cycles should be avoided to preserve viability. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | B6129SF2/J Mouse Bone Marrow Macrophages, B6129SF2/J BMM, B6-129F2 BM Macrophages |
| Species | B6129SF2/J Mouse |
| Cat.No | ABC-TC3038 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Macrophage |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
B6129SF2/J Bone Marrow Macrophages provide a reliable ex vivo platform to investigate macrophage activation, Toll-like receptor signaling, and cytokine secretion dynamics. They are particularly useful in modeling M1/M2 polarization, studying phagocytic capacity under infectious or tumor-mimicking conditions, and evaluating novel anti-inflammatory or immunomodulatory therapeutics in vitro. Additionally, these cells facilitate research into macrophage-mediated tissue remodeling and immunometabolism.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).